Publications by authors named "M La Farina"

Brexucabtagene autoleucel (brexu-cel) has revolutionized the treatment of patients affected by mantle cell lymphomas. In this prospective, observational multicentre study, we evaluated 106 patients, with longitudinal brexu-cel kinetics in peripheral blood monitored in 61 of them. Clinical outcomes and toxicities are consistent with previous real-world evidence studies.

View Article and Find Full Text PDF

Magnetotactic bacteria align to magnetic field lines while swimming in a behavior known as magnetotaxis. They are diverse phylogenetically and morphologically and include both unicellular and multicellular morphologies. The magnetotactic multicellular prokaryote (MMP) 'Candidatus Magnetoglobus multicellularis' has been extensively studied, even though it remains uncultured up to now.

View Article and Find Full Text PDF

Introduction: In recent decades, the global population has aged rapidly while socioeconomic inequalities in health have widened, with older adults who are most disadvantaged experiencing the poorest health. Functional limitations are key predictors of disability and quality of life and are therefore considered an important measure of how well individuals and populations are aging. We determine if educational inequalities in functioning have widened over time and across countries.

View Article and Find Full Text PDF
Article Synopsis
  • Acrylonitrile (AN) is an organic compound that can cause neurotoxicity, but the mechanism behind this is not fully understood; HIF-1α plays a crucial role in cellular response to low oxygen levels and may help with survival.
  • In lab studies, AN reduced the levels of HIF-1α and other proteins associated with cell survival and function, leading to mitochondrial damage and increased cell death.
  • Treatment that activates HIF-1α (like cobalt chloride) showed protective effects against neurotoxicity, suggesting that enhancing this pathway could be a potential strategy for mitigating the harmful effects of AN exposure.
View Article and Find Full Text PDF

Chronic Myeloid Leukemia (CML) is marked by the BCR::ABL1 fusion gene. Monitoring tyrosine kinase inhibitor (TKI) therapy response is crucial for treatment management, thus, limitations in Reverse Transcription quantitative PCR's (RT-qPCR) accuracy and sensitivity led to the exploration of alternative methods like digital PCR (dPCR). This study evaluated dPCR efficacy in detecting Minimal Residual Disease (MRD) in CML patients undergoing TKI therapy.

View Article and Find Full Text PDF